ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

DANSHENSU MITIGATES OXIDIZED LOW-DENSITY LIPOPROTEIN-INDUCED HUMAN VASCULAR ENDOTHELIAL CELL INJURY THROUGH ACTIVATION OF P38/JNK SIGNALING

Zhang, Lei*; Jia, Yuhua*; Zhao, Xiaoshan; Pan, Yunyun; Wan, Qiang; Zhou, Fenghua; Zhao, Dandan; Zhang, Yu; Su, Zhijie南方医科大学
Acta Medica Mediterranea2022DOI: 10.19193/0393-6384_2022_4_338
5阅读
引用收藏
分享

摘要

Introduction: This study investigated the effect of Danshensu (DSS) on oxidized low-density lipoprotein (ox-LDL) induced injury of cultured human umbilical vein endothelial cells (HUVEC). @@@ Materials and methods: The results showed that ox-LDL suppressed HUVEC viability, induced apoptosis and upregulated phosphorylation of p38 MAPK and c-Jun N-terminal kinase (JNK). DSS showed a protective effect against ox-LDL induced loss in cell viability and an increase in apoptosis. Furthermore, the suppressed cell viability and increased apoptosis induced by ox-LDL could be rescued by inhibitor of p38 (SB203580) and JNK (SP600125), which can effectively inhibit the protective effect of DSS on cell viability loss and apoptosis induced by ox-LDL. In vivo experiment with genetically deficient apolipoprotein E (ApoE) male mice of C57BL/6J strain (Apo E-/-) was also conducted which received DSS. @@@ Results: The aorta was harvested for hematoxylin and eosin staining and the result showed that DSS treatment ameliorated atherosclerotic lesions. Moreover, Western blot results revealed that DSS inhibits injury to HUVEC induced by ox-LDL, and the expression of p38 and JNK in apo E-/-mice was also deregulated. @@@ Conclusion: Collectively, we suggested that the protective effect of DSS against ox-LDL induced HUVEC apoptosis might, at least in part, be obtained via inhibition of the p38/JNK signaling pathway.

学科与关键词

关键词
Danshensuhuman umbilical vein endothelial cellsoxidized low-density lipoprotein
相关
加载中…
  • Safflor yellow A protects vascular endothelial cells from ox-LDL-mediated damage
    Zhang, Hu; Fan, Li-Juan; Liu, Jun; Zhu, Jia-Qi; Tan, Ting-Ting; Li, Ming*; Zhu, You-Li*Journal of Receptor and Signal Transduction Research, 2022, 42(1): 52-59.被引 3
  • Compound Danshen Dripping Pill inhibits hypercholesterolemia/atherosclerosis-induced heart failure in ApoE and LDLR dual deficient mice via multiple mechanisms
    Yang, Yanfang; Feng, Ke; Yuan, Liying; Liu, Yuxin; Zhang, Mengying; Guo, Kaimin; Yin, Zequn; Wang, Wenjia; Zhou, Shuiping; Sun, He; Yan, Kaijing; Yan, Xijun; Wang, Xuerui; Duan, Yajun*; Hu, Yunhui*; Han, Jihong*Acta Pharmaceutica Sinica B, 2023, 13(3): 1036-1052.被引 1
  • Resveratrol attenuates atherosclerotic endothelial injury through the Pin1/Notch1 pathway
    Yu, Guo-hui; Fang, Yong*Toxicology and Applied Pharmacology, 2022, 446: 116047.被引 7
查看全部 →

发表信息

论文状态
公开发表
期刊
Acta Medica Mediterranea
发表日期
2022
卷期
第 38 卷, 第 4 期
页码
2227-2232
DOI
10.19193/0393-6384_2022_4_338
语言
ITALIAN
期刊等级
4区
成果收录
SCIE
资助标注
Natural Science Foundation of China [81373574, 82004112]

作者

  • Z

    Zhang, Lei (通讯) (第一作者)

    henan univ tradit chinese med

  • J

    Jia, Yuhua (通讯)

    southern med univ · henan univ tradit chinese med

查看全部 9 位作者收起作者
  • Z

    Zhao, Xiaoshan

    southern med univ

  • P

    Pan, Yunyun

    southern med univ

  • W

    Wan, Qiang

    jiangxi prov peoples hosp

  • Z

    Zhou, Fenghua

    southern med univ

  • Z

    Zhao, Dandan

    southern med univ

  • Z

    Zhang, Yu

    southern med univ

  • S

    Su, Zhijie

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417